RTW Investments’s Burning Rock Biotech BNR Stock Holding History

RTW Investments’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,000	Closed	-$536K	–	126
2021 Q3	$536K	Hold	3,000	–	–	0.01%	118
2021 Q2	$884K	Hold	3,000	–	–	0.01%	111
2021 Q1	$808K	Hold	3,000	–	–	0.01%	106
2020 Q4	$693K	Hold	3,000	–	–	0.01%	98
2020 Q3	$752K	Hold	3,000	–	–	0.02%	89
2020 Q2	$810K	Buy	+3,000	New	+$822K	0.02%	75

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments's BNR Position: Q4 2021 in Review

RTW Investments sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 3,000 shares — an estimated $536K sold.

RTW Investments first reported a position in BNR in Q2 2020 and held it in 6 quarters. The position peaked at $884K in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

RTW Investments reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
RTW Investments sold 3,000 Burning Rock Biotech shares in Q4 2021, an estimated $536K.
RTW Investments first reported a position in Burning Rock Biotech in Q2 2020 and held it in 6 quarters.
RTW Investments's Burning Rock Biotech position peaked at $884K in Q2 2021.
62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on RTW Investments's 13F filing for Q4 2021, filed 14 Feb 2022.